Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness

Table 1 Demographics and clinicopathologic features associated with TMA cohort

Variable	Frequency	%
Race
African American	17	8.5
Asian	2	1
Caucasian	173	86.5
Other	8	4
Family history of prostate cancer
No	112	56
Yes	73	36.5
TNM stage
Local	132	66
Advanced	68	34
Gleason score
6	110	55
7 (3 + 4)	56	28
7 (4 + 3)	11	5.5
8	14	7
9–10	9	4.5
Extraprostatic extension
No	136	68
Yes	63	31.5
Lymph node metastases
No	195	97.5
Yes	3	1.5
Distant metastasis
No	165	82.5
Yes	6	3
Adjuvant therapy^a
None	169	84.5
Adjuvant radiation only	2	1
Chemotherapy^a
No	168	84
Yes	3	1.5
Radiation therapy^a
No	160	80
Yes	11	5.5
Hormonal therapy^a
No	160	80
Yes	12	6
Surgical margin status
Negative	169	84.5
Positive	31	15.5
Seminal vesicle involvement
No	186	93
Yes	14	7

Numbers do not always add up to 200 (or 100%) in some categories because of cases with missing data
^aAll treatment modalities were applied postoperatively

ISSN: 1475-2867